Method and composition for hyperthermally treating cells
View Patent ↗A method and composition for hyperthermally diagnosing and monitoring treatment of cells in an animal with photoacoustic sound and nanoparticles. The heat (temperature) and photoacoustic sound wave production inside the target tissue is measured. The desired temperature is achieved using a laser and photoacoustic imaging technique. Hyperthermia treatment of tissue in a target site applies a heat source to kill cells without protein denaturation. The method introduces an encapsulated dye that is released at a selected temperature in the target site to indicate that a threshold temperature has been reached to hyperthermally treat the tissue. In one embodiment, the composition releases the dye at a temperature of 42° C. to 56° C., and preferably about 45° C. to 49° C. The composition which can be a liposome composition encapsulating the dye can be introduced to the bloodstream of the patient to flow through the target site.
1. A method of evaluating malignant cells in a human patient, the method comprising the steps of:
injecting an antitumor antibody-labeled nanoparticle and a temperature indicating substance to form an antibody-labeled-nanoparticle-cell complex at the tumor site,
thereafter exposing the tumor site to a radiation energy source to heat the complex at the target site to achieve a temperature of the complex between about 45° C. to about 49° C. for about 1 femosecond to about 15 minutes,
thereafter assessing the acoustic sound produced from the nanoparticle at the site and,
correlating the acoustic sound with the presence or absence of malignant cells at the target site by photoacoustic imaging and/or ultrasound spectroscopy.
2. A method of evaluating malignant cells in a human patient, the method comprising the steps of:
injecting an antitumor antibody-labeled nanoparticle and a temperature indicating substance to form an antibody-labeled-nanoparticle-cell complex at the tumor site,
thereafter exposing the tumor site to a radiation energy source to heat the complex at the target site to achieve a temperature of the complex between about 47° C. to about 55° C. for about 0.5 minute to about 10 minutes,
thereafter assessing the acoustic sound produced from the nanoparticle at the site and,
correlating the acoustic sound with the presence or absence of malignant cells at the target site by photoacoustic imaging and/or ultrasound spectroscopy.
3. The method of claim 1 or claim 2 wherein the nanoparticle is selected from the group consisting of gold, diamond, platinum, and combinations thereof.
4. The method of claim 1 or claim 2 wherein the complex further comprises a compound selected from the group consisting of an antivascular endothelial growth factor, an antiproliferative agent, and combinations thereof.
5. The method of claim 1 or claim 2 wherein the radiation energy source is a light source, a laser source, a microwave source, an infrared source, or an ultrasonic source.
6. The method of claim 5 wherein the light source wavelength is between 350 nm to 1300 nm.
7. The method of claim 5 wherein the light source wavelength is between 450 nm to 600 nm.
8. The method of claim 1 or claim 2 wherein the nanoparticle size is between 2 nm to 700 nm.
9. The method of claim 1 or claim 2 wherein the nanoparticle size is between 50 nm to 250 nm.
10. The method of claim 1 or claim 2 comprising exposing the nanoparticle to the radiation energy source creating a photoacoustic sound wave temperature indicating temperature of about 45° C. to about 49° C.
11. The method of claim 1 or claim 2 wherein the acoustic sound is measured with an acoustic wave sensor or an acoustic wave detector.